表紙
市場調查報告書
商品編碼
1068654

細胞化驗分析及高內涵篩選市場:各用戶,各產品預測 - 附執行和顧問指南(定做的預測與分析,2022年∼2026年)

Cell Based Assay & High Content Screening Markets. Forecasts by User and Product. With Executive and Consultant Guides. including Customized Forecasting and Analysis. 2022 to 2026

出版日期: | 出版商: Howe Sound Research | 英文 266 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

細胞化驗分析是醫藥品開發和科學研究之柱,大流行後的現在,研究活動活性化。再加上新的技術,細胞化驗分析用於細胞功能的各個方面的檢測。

本報告提供全球細胞化驗分析及高內涵篩選市場相關調查,市場概要,以及技術趨勢,市場預測,各用戶類型,各產品級趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 市場指南

第2章 簡介和市場定義

  • 所謂細胞化驗分析
  • 臨床試驗的失敗
  • 感染疾病基於發揮大幅作用
  • 市場定義
  • 調查手法
  • 美國的醫療市場與醫藥品研究費的展望

第3章 細胞化驗分析-技術指南

  • 細胞培養
  • 細胞化驗
  • 細胞存活率化驗
  • 細胞生長化驗
  • 細胞毒性化驗
  • 細胞老化化驗
  • 細胞凋亡
  • 自動模糊
  • 壞死
  • 氧化壓力
  • 2D和3D
  • 訊號傳達途徑,GPCR
  • 免疫調節與抑制
  • 報導基因科技
  • CBA的設計與開發
  • 細胞化驗分析-要點

第4章 產業概要

  • 動態市場進入組織
    • 學術研究所
    • CRO
    • 基因儀器供應商
    • 細胞分離及顯示供應商
    • 細胞株及試劑供應商
    • 製藥公司
    • 審核機關
    • 認證機關

第5章 市場趨勢

  • 成長促進因素
  • 成長阻礙因素
  • 技術開發

第6章 細胞化驗分析最近的開發

第7章 主要細胞化驗分析企業的簡介

  • Abcam
  • Agilent
  • Aurora Instruments Ltd.
  • Axxam
  • Beckman Coulter Diagnostics
  • Becton, Dickinson and Company
  • BioIVT
  • Bio-Rad Laboratories, Inc.
  • BioTek Instruments
  • BioVision, Inc.
  • BMG Labtech
  • Cell Biolabs, Inc.
  • Cell Signaling Technology, Inc.
  • Charles River Laboratories
  • Cisbio Bioassays
  • Corning, Inc.
  • Cytovale
  • Enzo Life Sciences, Inc.
  • Eurofins DiscoverX Corporation
  • Evotec AG
  • Excellerate Bioscience
  • Fujifilm Cellular Dynamics International
  • Genedata
  • Hemogenix
  • Horizon Discovery
  • Invivogen
  • Leica Biosystems
  • Lonza Group Ltd.
  • Luminex Corp
  • Merck & Co., Inc
  • Miltenyi Biotec
  • Molecular Devices
  • Nanion
  • Ncardia
  • New England Biolabs, Inc.
  • Olympus
  • Origene Technologies
  • Perkin Elmer
  • Promega
  • Qiagen Gmbh
  • Reaction Biology
  • Recursion Pharma
  • Roche Diagnostics
  • Sartorius
  • Sartorius-ForteBio
  • Sartorius-IntelliCyt
  • Sony Biotechnology
  • SPT Labtech
  • Stemcells Technologies Canada Inc.
  • Tecan
  • Thermo Fisher Scientific Inc.
  • Vitro Biopharma

第8章 全球市場規模

  • 全球市場概要,各國
  • 全球市場-概要,各用戶
  • 全球市場-概要,各產品級

第9章 全球市場,各用戶類型

  • 製藥公司
  • 研究機關
  • 產業/化妝品產業

第10章 細胞化驗分析,各產品級

  • 設備
  • 試劑
  • 服務
  • 軟體

第11章 附錄

目錄

OVERVIEW:

Cell Based Assays are a mainstay of drug development and scientific research, and now, post pandemic, research activity is taking off. On top of this new technology is allowing Cell Based Assays to be used to measure any aspect of cell function. This market just keeps on growing with no end in sight. The workhorse of the pharmaceutical industry is becoming a central player in biotechnology.

This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity.

The technology is moving faster than the market. Genomics and Immunology are playing a role too. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

1 Market Guides

  • 1.1 Situation Analysis
  • 1.2 Guide for Executives and Marketing Staff
  • 1.3 Guide for Investment Analysts and Management Consultants

2 Introduction and Market Definition

  • 2.1 What are Cell Based Assays?
  • 2.2 Clinical Trial Failures
    • 2.2.1 Immuno-oncology Plays a Leading Role in Cell Based Assays
  • 2.3 Infectious Disease Will Play a Larger Role
  • 2.4 Market Definition
    • 2.4.1 Market Size
    • 2.4.2 Currency
    • 2.4.3 Years
  • 2.5 Methodology
    • 2.5.1 Authors
    • 2.5.2 Sources
  • 2.6 U.S. Medical Market and Pharmceutical Research Spending Perspective
    • 1.5.1 U.S. Expenditures for Pharmaceutical Research

3 Cell Based Assays - Guide to Technology

  • 3.1 Cell Cultures
    • 3.1.1 Cell Lines
    • 3.1.2 Primary Cells
    • 3.1.3 Stem Cells
    • 3.1.4 iPSC's - The Special Case
  • 3.2 Cell Assays
  • 3.3 Cell Viability Assays
  • 3.4 Cell Proliferation Assays
  • 3.5 Cytotoxicity Assays
  • 3.6 Cell Senescence Assays
  • 3.7 Apoptosis
  • 3.8 Autophagy
  • 3.9 Necrosis
  • 3.10 Oxidative Stress
  • 3.11 2D vs. 3D
  • 3.12 Signalling Pathways, GPCR
  • 3.13 Immune Regulation & Inhibition
  • 3.14 Reporter Gene Technology
  • 3.15 CBA Design & Development
  • 3.16 Cell Based Assays - The Takeaway

4 Industry Overview

  • 4.1 Players in a Dynamic Market
    • 4.1.1 Academic Research Lab
    • 4.1.2 Contract Research Organization
    • 4.1.3 Genomic Instrumentation Supplier
    • 4.1.4 Cell Separation and Viewing Supplier
    • 4.1.5 Cell Line and Reagent Supplier
    • 4.1.6 Pharmaceutical Company
    • 4.1.7 Audit Body
    • 4.1.8 Certification Body

5 Market Trends

  • 5.1 Factors Driving Growth
    • 5.1.1 Candidate Growth
    • 5.1.2 Immuno-oncology
    • 5.1.3 Genomic Blizzard
    • 5.1.4 Technology Convergence
    • 5.1.5 The Insurance Effect
  • 5.2 Factors Limiting Growth
    • 5.2.1 CBA Development Challenges
    • 5.2.2 Instrument Integration
    • 5.2.3 Protocols
  • 5.3 Technology Development
    • 5.3.1 3D Assays
    • 5.3.2 Automation
    • 5.3.3 Software
    • 5.3.4 Primary Cells
    • 5.3.5 Signalling and Reporter Genes
    • 5.3.6 The Next Five Years

6 Cell Based Assays Recent Developments

  • 6.1 Recent Developments - Importance and How to Use This Section
    • 6.1.1 Importance of These Developments
    • 6.1.2 How to Use This Section
  • 6.2 Nanolive closes a USD 20 million Funding Round
  • 6.3 Depixus Seeks to Commercialize 'Magnetic Tweezers' for Drug Discovery
  • 6.4 BioAuxilium Research Expands its Cell Signaling Assay Portfolio
  • 6.5 Droplet Genomics Debuts New Microfluidic Screening Platform
  • 6.6 DLP Plus Single-Cell Sequencing Method Spreads From Canada Cancer Labs Worldwide
  • 6.7 Secondcell Bio to Make Creation of Cell Lines Easy
  • 6.8 Nanolitre-scale cell assays developed with droplet microarraymass spec
  • 6.9 Thermo Fisher Scientific Acquires Cell Sorting Technology
  • 6.10 Cellink to Distribute Phasefocus High-Content Cell Imaging Platform
  • 6.11 Axxam and FUJIFILM Cellular Dynamics Announce Strategic Alliance
  • 6.12 Cancer Genetics to Acquire Organoid Startup Stemonix
  • 6.13 Curi Bio Acquires Artificial Intelligence Firm Dana Solutions
  • 6.14 CRISPR Screens Uncover Novel Cancer Therapy Targets
  • 6.15 ERS Genomics Licenses CRISPR-Cas9 Patents to Axxam
  • 6.16 New Transcriptomics Assay Facilitates Compound Screens
  • 6.17 Carta Biosciences Betting on Gene Interaction Mapping
  • 6.18 High-throughput Identifies cancer drug candidates
  • 6.19 Velabs Therapeutics partners with Alytas Therapeutics to develop a novel immune-based therapy for obesity
  • 6.20 InSphero platform selected to test Cyclerion's sGC stimulator technology
  • 6.21 OcellO to provide in vitro research services to Merus
  • 6.22 Charles River Laboratories to acquire Citoxlab
  • 6.23 Reaction Biology Corporation Purchases ProQinase GmbH

7 Profiles of Key Cell Based Assay Companies

  • 7.1 Abcam
  • 7.2 Agilent
  • 7.3 Aurora Instruments Ltd.
  • 7.4 Axxam
  • 7.5 Beckman Coulter Diagnostics
  • 7.6 Becton, Dickinson and Company
  • 7.7 BioIVT
  • 7.8 Bio-Rad Laboratories, Inc.
  • 7.9 BioTek Instruments
  • 7.10 BioVision, Inc.
  • 7.11 BMG Labtech
  • 7.12 Cell Biolabs, Inc.
  • 7.13 Cell Signaling Technology, Inc.
  • 7.14 Charles River Laboratories
  • 7.15 Cisbio Bioassays
  • 7.16 Corning, Inc.
  • 7.17 Cytovale
  • 7.18 Enzo Life Sciences, Inc.
  • 7.19 Eurofins DiscoverX Corporation
  • 7.20 Evotec AG
  • 7.21 Excellerate Bioscience
  • 7.22 Fujifilm Cellular Dynamics International
  • 7.23 Genedata
  • 7.24 Hemogenix
  • 7.25 Horizon Discovery
  • 7.26 Invivogen
  • 7.27 Leica Biosystems
  • 7.28 Lonza Group Ltd.
  • 7.29 Luminex Corp
  • 7.30 Merck & Co., Inc
  • 7.31 Miltenyi Biotec
  • 7.32 Molecular Devices
  • 7.33 Nanion
  • 7.34 Ncardia
  • 7.35 New England Biolabs, Inc.
  • 7.36 Olympus
  • 7.37 Origene Technologies
  • 7.38 Perkin Elmer
  • 7.39 Promega
  • 7.40 Qiagen Gmbh
  • 7.41 Reaction Biology
  • 7.42 Recursion Pharma
  • 7.43 Roche Diagnostics
  • 7.44 Sartorius
  • 7.45 Sartorius-ForteBio
  • 7.46 Sartorius-IntelliCyt
  • 7.47 Sony Biotechnology
  • 7.48 SPT Labtech
  • 7.49 Stemcells Technologies Canada Inc.
  • 7.50 Tecan
  • 7.51 Thermo Fisher Scientific Inc.
  • 7.52 Vitro Biopharma

8 Global Market Size

  • 8.1 Global Market Overview by Country
    • 8.1.1 Table - Global Market by Country
    • 8.1.2 Chart - Global Market by Country
  • 8.2 Global Market by User - Overview
    • 8.2.1 Table - Global Market by User
    • 8.2.2 Chart - Global Market by User - Base/End Year Comparison
    • 8.2.3 Chart - Global Market by User - Base Year
    • 8.2.4 Chart - Global Market by User - End Year
    • 8.2.5 Chart - Global Market by User - Share by Year
  • 8.3 Global Market by Product Class - Overview
    • 8.3.1 Table - Global Market by Product Class
    • 8.3.2 Chart - Global Market by Product Class - Base/End Year Comparison
    • 8.3.3 Chart - Global Market by Product Class - Base Year
    • 8.3.4 Chart - Global Market by Product Class - End Year
    • 8.3.5 Chart - Global Market by Product Class - Share by Year

9 Global Market by User Type

  • 9.1 Pharma
    • 9.1.1 Table Pharma - by Country
    • 9.1.2 Chart - Pharma Growth
  • 9.2 Research
    • 9.2.1 Table Research - by Country
    • 9.2.2 Chart - Research Growth
  • 9.3 Industry/Cosmetic
    • 9.3.1 Table Industry/Cosmetic - by Country
    • 9.3.2 Chart - Industry/Cosmetic Growth

10 Cell Based Assay by Product Class

  • 10.1 Instrument
    • 10.1.1 Table Instrument - by Country
    • 10.1.2 Chart - Instrument Growth
  • 10.2 Reagent
    • 10.2.1 Table Reagent - by Country
    • 10.2.2 Chart - Reagent Growth
  • 10.3 Services
    • 10.3.1 Table Services - by Country
    • 10.3.2 Chart - Services Growth
  • 10.4 Software
    • 10.4.1 Table Software - by Country
    • 10.4.2 Chart - Software Growth

11 Appendices

  • 11.1 FDA Cancer Drug Approvals by Year
  • 11.2 Clinical Trials Started 2010 to 2016
  • 11.3 Share of Pharma R&D by Country

Table of Tables

  • Table 1: The Large Variety of Cell Lines
  • Table 2: Some Common Viability Assays
  • Table 3: Oxidative Stress Related Diseases
  • Table 4: Important Signalling Pathways
  • Table 5: Market Players by Type
  • Table 6: Five Factors Driving Growth
  • Table 7: Three Factors Limiting Growth
  • Table 8: Global Market by Region
  • Table 9: Global Market by User
  • Table 10: Global Market by Product Class
  • Table 11: Pharma by Country
  • Table 12: Research by Country
  • Table 13: Industry/Cosmetic by Country
  • Table 14: Instrument by Country
  • Table 15: Reagent by Country
  • Table 16: Services by Country
  • Table 17: Software by Country

Table of Figures

  • Figure 1: Reasons for clinical Failure by Phase
  • Figure 2: Immunotherapy Clinical Trial Growth
  • Figure 3: Pharmaceutical Research Expenditures 2001 to 2017 ($Billion)
  • Figure 4: Oxidative Stress and Free Radical Toxicity
  • Figure 5: FDA Cancer Drug Approvals
  • Figure 6: The Changing Approach to Cancer Diagnostics
  • Figure 7: Growth rates of Cell Based Assays by Product Class
  • Figure 8: Global Market Share Chart
  • Figure 9: Global Market by User - Base vs. End Year
  • Figure 10: Global Market by User Base Year
  • Figure 11: Global Market by User End Year
  • Figure 12: User Share by Year
  • Figure 13: Global Market by Product Class - Base vs. End Year
  • Figure 14: Global Market by Product Class Base Year
  • Figure 15: Global Market by Product Class End Year
  • Figure 16: Product Class Share by Year
  • Figure 17: Pharma Growth
  • Figure 18: Research Growth
  • Figure 19: Industry/Cosmetic Growth
  • Figure 20: Instrument Growth
  • Figure 21: Reagent Growth
  • Figure 22: Services Growth
  • Figure 23: Software Growth
  • Figure 24: FDA Cancer Drug Approvals by Year
  • Figure 25: Clinical Trials for Immunotherapy by Year
  • Figure 26: Share of Pharma R&D by Country